CASI Pharmaceuticals, Inc. (CASIF) stock
CASIFOTCPharmaceutical PreparationsFiscal year ends December 31
$0.10+0.00 (0.00%)
Close on Oct 19, 2026Market cap –P/E –Yield –
CASI Pharmaceuticals revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
For fiscal 2025 it was $20.71M, down 27.4% from the year before. The highest annual figure on record is $43.11M in fiscal 2022.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $20.71M | -27.4% |
| FY2024 | Dec 31, 2024 | $28.54M | -15.8% |
| FY2023 | Dec 31, 2023 | $33.88M | -21.4% |
| FY2022 | Dec 31, 2022 | $43.11M | +42.9% |
| FY2021 | Dec 31, 2021 | $30.17M | +99.2% |
| FY2020 | Dec 31, 2020 | $15.14M | – |
See a number that looks wrong?